Venetoclax Combination Treatment of Acute Myeloid Leukemia in Adolescents and Young Adult Patients

Venetoclax Combination Treatment of Acute Myeloid Leukemia in Adolescents and Young Adult Patients

Over the past two decades, the prognosis in adolescents and young adults (AYAs) diagnosed with acute myeloid leukemia (AML) has significantly improved. The standard intensive cytotoxic treatment approach for AYAs with AML, consisting of induction chemotherapy with anthracycline/cytarabine combinatio...

Full description

Bibliographic Details
Main Authors: Elena Chatzikalil, Kleoniki Roka, Panagiotis T. Diamantopoulos, Efthymia Rigatou, Georgia Avgerinou, Antonis Kattamis, Elena E. Solomou
Format: Article
Language:English
Published: MDPI AG 2024-04-01
Series:Journal of Clinical Medicine
Subjects:
Bcl-2 inhibitor
venetoclax
acute myeloid leukemia
targeted therapy
adolescents
young adults
Online Access:https://www.mdpi.com/2077-0383/13/7/2046

Internet

https://www.mdpi.com/2077-0383/13/7/2046

Similar Items